Latest News about SYK
Recent news which mentions SYK
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth
January 29, 2025
From Benzinga
From Benzinga
US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings
January 29, 2025
From Benzinga
Tesla, Starbucks And 3 Stocks To Watch Heading Into Wednesday
January 29, 2025
From Benzinga
Earnings Scheduled For January 28, 2025
January 28, 2025
From Benzinga
From Benzinga
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
January 12, 2025
From Benzinga
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
January 07, 2025
From Benzinga
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
January 07, 2025
From Benzinga
From Benzinga
From Benzinga
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
December 15, 2024
From Motley Fool
From Benzinga
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
December 02, 2024
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Stryker
December 02, 2024
Tickers
SYK
From Benzinga
This Gap Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
December 02, 2024
From Benzinga
Jim Cramer Likes Cava Group, Calls This Utilities Stock 'Terrific'
November 01, 2024
From Benzinga
Tech Stocks Rise Ahead Of Key Earnings, Gold Smashes Records, Bitcoin Nears All-Time Highs: What's Driving Markets Tuesday?
October 29, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.